GeneVentiv Therapeutics, Inc.
PrivateLast Round
Grant
Apr 16, 2024
Total Funding Raised
$4.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GeneVentiv Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was a Grant round in April 2024.
GeneVentiv Therapeutics, Inc. is a drug discovery company that develops gene therapies designed to treat rare genetic disorders. The company's treatments address hemophilia and Pompe disease, aiming to provide long-lasting and effective solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneVentiv Therapeutics, Inc. Comparables
Compare GeneVentiv Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ASC Therapeutics | 77% | |
| Roche Holding | 71% | |
| Pfizer | 69% |
For institutional investors. Book with your work email.
GeneVentiv Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2024 | ||||
| Seed | Sep 1, 2022 | ||||
| Debt | Jun 8, 2022 | ||||
| Grant | Mar 16, 2022 |
For institutional investors. Book with your work email.
GeneVentiv Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KickStart Venture Services | Grant |
| North Carolina Biotechnology Center | Debt |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 47% MoM.
- Mar 3, 2026
Monthly visitors increased 126% MoM.
For institutional investors. Book with your work email.
GeneVentiv Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneVentiv Therapeutics, Inc.'s valuation, stock price, and market status.
Is GeneVentiv Therapeutics, Inc. a public or private company?
GeneVentiv Therapeutics, Inc. is a private company.
What is the current stock price of GeneVentiv Therapeutics, Inc.?
GeneVentiv Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks GeneVentiv Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneVentiv Therapeutics, Inc. worth (valuation)?
Valuation information for GeneVentiv Therapeutics, Inc. is not publicly available.
Can I buy GeneVentiv Therapeutics, Inc. stock?
GeneVentiv Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneVentiv Therapeutics, Inc.'s last funding round?
GeneVentiv Therapeutics, Inc.'s most recent funding round was Grant on April 16, 2024.
Who are the main investors in GeneVentiv Therapeutics, Inc.?
Key investors in GeneVentiv Therapeutics, Inc. include KickStart Venture Services, North Carolina Biotechnology Center, National Heart, Lung, and Blood Institute.
Will GeneVentiv Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for GeneVentiv Therapeutics, Inc..
How can I track GeneVentiv Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GeneVentiv Therapeutics, Inc.'s shares on secondary markets.